Health-related QoL Following TAVI TAo, TAVI TF and AVR

NCT ID: NCT03583398

Last Updated: 2018-07-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

97 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2018-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study was to evaluate short- and long-term changes in QoL in patients undergoing TAVI and to assess differences in patient QoL when using the TAVI TAo approach compared with the transfemoral approach (TAVI TF) and surgical aortic valve replacement (SAVR).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAVI TAo

transcatheter aortic valve implantation, surgical aortic valve replacement

Intervention Type PROCEDURE

Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.

TAVI TF

transcatheter aortic valve implantation, surgical aortic valve replacement

Intervention Type PROCEDURE

Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.

AVR

transcatheter aortic valve implantation, surgical aortic valve replacement

Intervention Type PROCEDURE

Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcatheter aortic valve implantation, surgical aortic valve replacement

Transcatheter aortic valve implantation using transaortic and transfemoral access and surgical aortic valve replacement.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aortic valve stenosis

Exclusion Criteria

\-
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut für Pharmakologie und Präventive Medizin

NETWORK

Sponsor Role collaborator

Medical University of Gdansk

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aleksandra Stańska

MSc, Psychologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MUGdansk

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

TAVR for Aortic Valve Disease
NCT05439863 RECRUITING
TAVR With Echocardiography Guidance
NCT07035847 RECRUITING NA